Final Programme - iuphar

W19 Influence of degeneration and repair in the CNS
and periphery
Mon 417 The study of ABCB1 polymorphisms in Romanian epileptic patients
Ioana Corina Bocsan, (Romania), AD Buzoianu, FC Militaru, R Popp, A Trifa, LP Dumbrava,
E Brusturean
Mon 418 The effect of chemical absence model on the progression of kindling in wistar rats
Nihan Carcak, (Turkey), M Sahiner, E Sakallý, K Tezcan, R Gülhan, F Onat
Mon 419 Calcium antagonistic effects of some antimigraine drugs in rat isolated basilar artery
Edip Guvenc Cekic, (Turkey), M Tuncer
Mon 420 Comparison of GABA-A in vivo occupancy in rat brain and spinal cord
Rebecca Fish, (UK), S Able, C Powell, L Booth
Mon 421 Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2
ratio
Mei Gao, (PR China), W-C Zhang, J-J Hu, G-H Du
Mon 422 Neuroprotective effect of dimebon in rats with intracerebral post-traumatic hematoma (hemorrhagic
stroke)
TL Garibova, TA Voronina, SA Litvinova, VV Grigoriev, SO Bachurin, Tatiana S Kalinina, (Russian
Federation)
Mon 423 P53 in amyloid-β peptide-induced apoptosis in cerebral endothelial cell
Ming-Jen Hsu, (Taiwan), Y-F Chuang, P-T Chiu, C-Y Wang, J-R Sheu
Mon 424 Paraquat activates Nrf2-ARE pathway: implication of decrease in proteasome activity in dopaminemediated
cytotoxicity
Yasuhiko Izumi, (Japan), S Matsushima, N Yamamoto, T Kume, H Sawada, A Akaike
Mon 425 The effect of KYP-2047, a prolyl oligopeptidase inhibitor, on extracellular neurotensin- and substance
P-like-immunoreactivity in the rat brain
Aaro Jalkanen, (Finland), K Savolainen, M Forsberg
Mon 426 Nephroprotective activity of the low-esterified pectins
Maxim Khotimchenko, (Russian Federation), A Kropotov, Y Khotimchenko
Mon 427 Association study of single nucleotide polymorphisms in the COMT gene and Korean autism spectrum
disorders
Soon Ae Kim, (South Korea), HJ Yoo, IH Cho, M Park
Mon 428 Genome-wide association scan of Korean autism spectrum disorders with language delay
Soon Ae Kim, (South Korea), SY Yang
Mon 429 Neuroprotective effect of mildronate, a mitochondria-targeted drug, in Parkinson’s disease model in
rats
Vija Klusa, (Latvia), J Pupure, S Isajevs, D Svirina, U Beitnere, B Jansone, J Rumaks, S Svirskis,
R Vilskersts, I Kalvinsh
Mon 430 Acute Allopregnanolone administration may exacerbate, rather than attenuate, striatal damage during
ischaemia in vitro
Steve Knight, (UK), C Davidson, A Young, C Gibson
Mon 431 Study of time dependence of afobazol and mexidol protective activity in itracerebral posttraumatic
hematoma model
Valentina Krayneva, (Russian Federation), A Fedorenko, S Seredenin
194 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area